Inventor · disambiguated record
Kyle Jacoby
Also filed as: JACOBY KYLE
11 granted patents·12 pending applications·20 citations·filing 2015–2025
86Inventor score
Files withPACT PHARMA INC12SEATTLE CHILDRENS HOSPITAL4ADOC SSF LLC3SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST3FEDERATION BIO INC1
Top patents by PatentIndex Score
23 records- 0193US9943612B2Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmidSEATTLE CHILDRENS HOSPITAL·Filed 2015·Granted Apr 17, 2018·12 cites·11 claims
- 0292US10584357B2Primary cell gene editingPACT PHARMA INC·Filed 2019·Granted Mar 10, 2020·4 cites·7 claims
- 0388US11304978B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyPACT PHARMA INC·Filed 2020·Granted Apr 19, 2022·2 cites·24 claims
- 0486US10550406B2Primary cell gene editingPACT PHARMA INC·Filed 2019·Granted Feb 4, 2020·1 cites·11 claims
- 0583US10676758B1Primary cell gene editingPACT PHARMA INC·Filed 2020·Granted Jun 9, 2020·1 cites·26 claims
- 0680US12385070B2Homology directed repair compositions for the treatment of hemoglobinopathiesSEATTLE CHILDRENS HOSPITAL·Filed 2023·Granted Aug 12, 2025·0 cites·27 claims
- 0780US2025250587A1Primary cell gene editingADOC SSF LLC·Filed 2025·Application pending·0 cites
- 0877US2021395783A1Primary cell gene editingPACT PHARMA INC·Filed 2021·Application pending·0 cites
- 0972US12247061B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyADOC SSF LLC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 1072US10711283B2Primary cell gene editingPACT PHARMA INC·Filed 2020·Granted Jul 14, 2020·0 cites·25 claims
- 1172US2020299730A1Primary cell gene editingPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 1271US2023054471A1Long poly(a) plasmids and methods for introduction of long poly(a) sequences into the plasmidSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2022·Application pending·0 cites
- 1365US2021085720A1Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 1464US11400169B2Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmidSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted Aug 2, 2022·0 cites·20 claims
- 1562US12110499B2Homology directed repair compositions for the treatment of hemoglobinopathiesSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted Oct 8, 2024·0 cites·18 claims
- 1660US2024066063A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPYPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 1759US2023355762A1Compositions and methods for the treatment of cancer using next generation engineered t cell therapyPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 1858US2023136076A1Methods of determining gene editing eficiencies in cellsPACT PHARMA INC·Filed 2022·Application pending·0 cites
- 1957US2023165913A1Microbial consortiaFEDERATION BIO INC·Filed 2022·Application pending·0 cites
- 2053US12359247B2Methods of performing GUIDE-Seq on primary human T cellsADOC SSF LLC·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 2152US2022010274A1Personalized neoantigen-specific adoptive cell therapiesPACT PHARMA INC·Filed 2021·Application pending·0 cites
- 2247US2021309995A1Homology-directed repair template design and delivery to edit hemoglobin-related mutationsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2019·Application pending·0 cites
- 2339US2018327781A1Novel rna-based vector system for transient and stable gene expressionSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kyle Jacoby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →